Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
about
Immune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to PathogenicityTsetse Flies (Glossina) as Vectors of Human African Trypanosomiasis: A ReviewEliminating the Neglected Tropical Diseases: Translational Science and New Technologies.TcTASV-C, a protein family in Trypanosoma cruzi that is predominantly trypomastigote-stage specific and secreted to the mediumDevelopment of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sicknessThe interaction of classical complement component C1 with parasite and host calreticulin mediates Trypanosoma cruzi infection of human placenta.Diversity-oriented synthesis yields a new drug lead for treatment of chagas diseaseDevelopment of peptide-based lineage-specific serology for chronic Chagas disease: geographical and clinical distribution of epitope recognition.Performance of parasitological and molecular techniques for the diagnosis and surveillance of gambiense sleeping sicknessSerum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatmentThe evolution of trypanosomatid taxonomy.IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic testPolyfunctional T cell responses in children in early stages of chronic Trypanosoma cruzi infection contrast with monofunctional responses of long-term infected adults.Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.The use of a heterogeneously controlled mouse population reveals a significant correlation of acute phase parasitemia with mortality in Chagas disease.Usefulness of real time PCR to quantify parasite load in serum samples from chronic Chagas disease patients.Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversityPerturbed T cell IL-7 receptor signaling in chronic Chagas disease.Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment.Orientation of DNA Minicircles Balances Density and Topological Complexity in Kinetoplast DNA.Tsetse Control and Gambian Sleeping Sickness; Implications for Control Strategy.Novel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity.Carbohydrate Recognition Specificity of Trans-sialidase Lectin Domain from Trypanosoma congolenseThe efficacy of 2-nitrovinylfuran derivatives against Leishmania in vitro and in vivoA novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazoleHuman African Trypanosomiasis in the Kafue National Park, ZambiaDevelopment and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis.Opportunities and challenges in chronic Chagas cardiomyopathyVFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis.Screening of Fungi for Biological Control of a Triatomine Vector of Chagas Disease: Temperature and Trypanosome Infection as Factors.GRAIL and Otubain-1 are Related to T Cell Hyporesponsiveness during Trypanosoma cruzi InfectionTrypanosoma cruzi population dynamics in the Central Ecuadorian Coast.Acute Chagas outbreaks: molecular and biological features of Trypanosoma cruzi isolates, and clinical aspects of acute cases in Santander, Colombia.Detection and Quantification of Viable and Nonviable Trypanosoma cruzi Parasites by a Propidium Monoazide Real-Time Polymerase Chain Reaction Assay.Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity.Chagas' heart disease: gender differences in myocardial damage assessed by cardiovascular magnetic resonance.Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds.Lineage-specific serology confirms Brazilian Atlantic forest lion tamarins, Leontopithecus chrysomelas and Leontopithecus rosalia, as reservoir hosts of Trypanosoma cruzi II (TcII).Evaluation of the in vitro antiplasmodial, antileishmanial, and antitrypanosomal activity of medicinal plants used in saudi and yemeni traditional medicine.
P2860
Q26742172-6F232BDA-57DC-4ADE-AE19-736390A9339AQ26748948-D9D5AACC-7FEE-405A-BC20-AA5A200D82BDQ26765026-CCB14E1A-33B3-4EF1-BCEA-BD8C398C9D8DQ27309739-4F498F15-6A14-46D3-8B9D-78CA1F6AADA5Q28555229-FEBFD69A-612A-4E54-A74A-A4B62E2BFD46Q28817181-859FA43D-B2A6-493C-BCB2-1432E5A28331Q31134134-E417B97D-ABA5-45D1-888A-738B86B0832AQ33636200-3956B914-69B9-4D1F-9D82-5D9E3FFD325EQ33650335-E5221230-0DB0-4347-A8E7-8D2EE88B51B6Q33748367-16F66E33-94E7-46C1-95C8-CABEAC46FF08Q33762602-70B15A6E-721F-409E-8774-11E5122394D9Q33776260-7B9D762B-AE7A-4999-BDD2-56161385C26FQ34395015-777D82D1-BFF1-4820-B770-76D6A1275381Q35071204-DA3436C9-941F-4726-9A41-AAB6A0293B94Q35109189-44CB8F41-FA28-4176-B80D-5B274A628489Q35126647-0EF4630E-19A4-4D8D-8413-B38727FBA0EFQ35204314-FA795BCC-A7E3-4280-A2A5-E440A406FA93Q35333873-43A3886C-2087-48D2-9CDF-83F2D7AAC2CDQ35348204-FAB81A8B-E098-40AB-9717-8AD9EA4C02ECQ35652603-9D7C84CD-4B5B-4685-BCC8-D3A112D08287Q35674031-FF62B511-8E5D-4504-801D-DA3B47899750Q35744138-92CBDFA7-828D-4F7D-93ED-1C2985508E07Q35758417-32B0E8ED-507F-4D46-8C54-509A91BEC698Q35810603-358A0CA3-339F-430D-97BE-DF697F01579BQ35810652-0C6EDFB4-39CA-4DE9-9B71-B62185EE8823Q35810796-ED409601-0F99-48C0-AD56-6628846D0747Q36022541-9C5613CC-8205-4BA3-ADD0-3B0708E3C780Q36086604-049FD166-9665-4EB6-BDFF-8E3468AA0936Q36108560-246424DC-0805-4AA0-B913-07713A77C60DQ36148993-78145158-0FE5-479C-8E74-5E80A996B37DQ36195222-BC49F509-C971-42F4-A733-48BE515E2D74Q36257442-50E9BAAB-1ADB-4A0C-ADDB-94427928DCB0Q36318615-4CFAFCCB-4DEE-4A82-B8AD-32350866C655Q36324922-2E2582E4-48DF-49FA-B9E6-D2CDACCA98BBQ36958490-E583A9F0-7107-4AC3-8997-71A47C21A278Q37308658-87D9B0BB-4F59-4A0C-8922-EE75A21814B7Q37444455-F2DCCB65-6B8D-422E-8384-4AFD77F9D9BAQ38777214-601DB004-74AC-49B1-A39D-768A75A4C0F0Q39129483-55899339-99A2-485F-B42C-15B3422EDE0BQ39198636-56BB1A7F-B59D-4B61-8AFE-1342CDAFC7F5
P2860
Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
@en
type
label
Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
@en
prefLabel
Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
@en
P921
P1476
Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis
@en
P304
v-xii, 1-100
P5008
P577
2012-01-01T00:00:00Z